You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DNA Damage Response

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Mesothelioma, Uveal Melanoma, Renal Cell Carcinoma Trial in Gainesville, Miami, Orlando (Niraparib)

Completed
  • Mesothelioma
  • +3 more
  • Gainesville, Florida
  • +2 more
Jan 4, 2023

ATM Gene Mutation, BRCA1 Gene Mutation, BRCA2 Gene Mutation Trial in Sacramento (Niraparib, Niraparib Tosylate Monohydrate,

Recruiting
  • ATM Gene Mutation
  • +16 more
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Oct 27, 2022

Metastatic or Locally Advanced Unresectable Solid Tumors Trial in Canada, Spain, United States (M1774, Drug A (DNA Damage

Recruiting
  • Metastatic or Locally Advanced Unresectable Solid Tumors
  • Houston, Texas
  • +4 more
Jul 7, 2022

SNPs in p53 and p53 Response Elements on Inflammatory Response

Completed
  • HIV-1 Seropositive
  • +3 more
    • Research Triangle Park, North Carolina
      NIEHS Clinical Research Unit (CRU)
    Jan 21, 2023

    Advanced Solid Tumours Trial in France, Spain, United States (Ceralasertib)

    Recruiting
    • Advanced Solid Tumours
    • Tucson, Arizona
    • +31 more
    Jan 13, 2023

    Non Small Cell Lung Cancer Trial in Newcastle Upon Tyne (Radiotherapy, Olaparib Oral Tablet [Lynparza], AZD1390)

    Recruiting
    • Non Small Cell Lung Cancer
    • Radiotherapy
    • +5 more
    • Newcastle Upon Tyne, United Kingdom
      Freeman Hospital, Newcastle upon Tyne Hospitals NHS Trust
    Sep 20, 2022

    Lung Cancer Trial in Korea, Republic of (Olaparib+Bevacizumab to SCLC patients)

    Recruiting
    • Lung Cancer
    • Olaparib+Bevacizumab to SCLC patients
    • Seoul, Gangnam-gu, Korea, Republic of
    • +3 more
    Nov 9, 2022

    Bile Duct Cancer, Chemo Effect Trial in Seoul (AZD6738, Durvalumab, Olaparib)

    Recruiting
    • Bile Duct Cancer
    • Chemotherapy Effect
    • Seoul, Korea, Republic of
      Seoul National University Hospital
    Sep 22, 2021

    Advanced Pancreatic Carcinoma, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8 Trial in

    Recruiting
    • Advanced Pancreatic Carcinoma
    • +27 more
    • Gainesville, Florida
    • +3 more
    Jan 3, 2023

    Using Breath, Cell Free DNA and Image Analysis to PRedIct Normal

    Recruiting
    • Prostate Cancer
    • +3 more
    • Stereotactic Body Radiotherapy
    • Edinburgh, Mid Lothian, United Kingdom
      Edinburgh Cancer Centre, Western General Hospital
    Apr 5, 2022

    Breast Cancer, Brain Metastases, Adult Trial in Birmingham, Chapel Hill, Durham (Olaparib, Stereotactic Radiosurgery,

    Not yet recruiting
    • Breast Cancer
    • Brain Metastases, Adult
    • (no location specified)
    Oct 25, 2021

    Advanced Solid Tumor, Breast Cancer Trial (Niraparib, M4344)

    Withdrawn
    • Advanced Solid Tumor
    • Breast Cancer
    • (no location specified)
    Jun 24, 2021

    Afamelanotide Evaluated as Skin DNA Repair Therapy in Healthy Volunteers Trial in Clinuvel Investigational Site (Afamelanotide)

    Recruiting
    • Afamelanotide Evaluated as Skin DNA Repair Therapy in Healthy Volunteers
    • Clinuvel Investigational Site, United Kingdom
      CLINUVEL Investigational Site
    Nov 9, 2022

    DDR Gene Mutation, Metastatic Solid Tumor Trial in Seoul (Nivolumab)

    Unknown status
    • DDR Gene Mutation
    • Metastatic Solid Tumor
    • Seoul, Chongro-ku, Korea, Republic of
    • +1 more
    Feb 16, 2021

    Granulosa Cell DNA Damage in Success of Assisted Reproductive

    Not yet recruiting
    • DNA Damage
    • Granulosa Cells
      • (no location specified)
      Sep 24, 2022

      Triple Negative Breast Cancer, TNBC - Triple-Negative Breast Cancer, Breast Cancer Trial in United States (Pembrolizumab,

      Recruiting
      • Triple Negative Breast Cancer
      • +2 more
      • Basking Ridge, New Jersey
      • +6 more
      Sep 15, 2021

      Advanced Breast Cancer Trial in Seoul (Olaparib, Fulvestrant)

      Not yet recruiting
      • Advanced Breast Cancer
      • Seoul, Korea, Republic of
        Seoul National University Hospital
      Sep 12, 2022

      Metastatic Pancreatic Cancer Trial in Barcelona, La Coruña, Santander (olaparib+durvalumab)

      Recruiting
      • Metastatic Pancreatic Cancer
      • Barcelona, Spain
      • +2 more
      Dec 29, 2022

      Castration Resistant Prostatic Cancer, Metastatic Prostate Cancer Trial in San Francisco (Pembrolizumab, Chemotherapy)

      Active, not recruiting
      • Castration Resistant Prostatic Cancer
      • Metastatic Prostate Cancer
      • San Francisco, California
        University of California, San Francisco
      May 17, 2022

      Refractory Cancer Trial in Seoul (AZD6738, Paclitaxel)

      Completed
      • Refractory Cancer
      • Seoul, Korea, Korea, Republic of
        Samsung Medical Center
      Jun 13, 2022

      Metastatic Malignant Solid Tumor, Unresectable Malignant Solid Tumor Trial (Biopsy, Diagnostic Imaging, Novobiocin Sodium)

      Not yet recruiting
      • Metastatic Malignant Solid Neoplasm
      • Unresectable Malignant Solid Neoplasm
      • Biopsy
      • +2 more
      • (no location specified)
      Jan 14, 2023

      Chronic Lymphocytic Leukemia Trial in Salt Lake City (RP-3500 in combination with Olaparib)

      Recruiting
      • Chronic Lymphocytic Leukemia
      • RP-3500 in combination with Olaparib
      • Salt Lake City, Utah
        Huntsman Cancer Institute at the University of Utah
      Sep 23, 2022

      Hypofractionated Radiation-Induced DNA Damage in Breast Cancer

      Not yet recruiting
      • Breast Carcinoma
      • Invasive Breast Carcinoma
      • Biopsy
      • +2 more
      • Houston, Texas
        M D Anderson Cancer Center
      Nov 28, 2022

      Acute and Chronic Organophosphate Toxicity

      Recruiting
      • Neuroinflammatory Response
      • +5 more
      • exposure to organophosphates
      • Alexandria, Egypt
        Alexandria Main University Hospital
      Aug 27, 2023

      Ultraviolet Rays; Injury, DNA Adduct Formation, DNA Damage, Radiation Induced Trial in Copenhagen NV (Ultraviolet radiation)

      Active, not recruiting
      • Ultraviolet Rays; Injury
      • +3 more
      • Ultraviolet radiation
      • Copenhagen NV, Denmark
        Bispebjerg Hospital, Department of Dermatology
      Jul 19, 2022